Thyrocare Technologies Ltd share price logo

Thyrocare Technologies Ltd

NSE: THYROCARE

BSE: 539871

Small Cap

Healthcare Sector

538.50

-5.95

(-1.09%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Thyrocare Technologies shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-54%

Searches for Thyrocare Technologies on INDmoney have decreased by 54% over the last 30 days.

Average holding period of indmoney investors

24 days

INDmoney investors hold Thyrocare Technologies shares for an average of 24 days.

Key Events for Thyrocare Technologies

Last Dividend Declared

7.00 per share, declared on 07/05/2026

View Dividend History

Thyrocare Technologies Stock Performance

as on September 16, 2026 at 5:28 pm IST

  • Day's Low

    Day's High

    ₹532.75
    ₹549.45
    downward going graph

    1.07%

    Downside

    2.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹342.55
    ₹662.00
    downward going graph

    36.39%

    Downside

    22.93%

    Upside

    downward going graph

Thyrocare Technologies share price movements today

Previous Close
₹544.45
Open
₹541.45
Volume
1.30L
Upper Circuit
₹653.30
Lower Circuit
₹435.60
Day's Low - High
₹532.75 - ₹549.45
52 Week Low - High
₹342.55 - ₹662.00

Thyrocare Technologies Historical Returns

1 Month Return
-11.99 %
3 Month Return
+ 2.03 %
1 Year Return
+ 37.02 %
3 Year Return
+ 180.1 %
5 Year Return
+ 28.11 %

Thyrocare Technologies Fundamentals

as on September 16, 2026 at 11:58 am IST

Market Cap

₹8,665.76 Cr

Return on Equity (ROE)

27.11

PE Ratio (TTM)

49.72

Return on capital employed (ROCE)

35.67

Industry PE ratio

97.37

Beta (LTM)

0.55

P/B Ratio

11.36

Dividend Yield

4

PEG Ratio

11.4

Quarterly Earnings Growth YOY

34.06

EPS (TTM)

10.23

Book Value

32.21

Thyrocare Technologies Stock Valuation

as on September 16, 2026 at 11:58 am IST

Thyrocare Technologies in the last 5 years

  • Overview

  • Trends

Lowest (18.71x)

June 23, 2022

Today (49.72x)

September 11, 2026

Industry (97.37x)

September 11, 2026

Highest (91.79x)

October 27, 2020

LowHigh

Today’s Price to Earnings Ratio: 49.72x

Thyrocare Technologies Technical Analysis

Track how Thyrocare Technologies technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish11
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.01
Bullish
CCI (20)
70.04
Neutral
RSI (14)
59.77
Neutral
Momentum (10)
3.15
Bearish
ADI (14)
28.12
Bullish
Ultimate Oscillator (7,14,28)
65.61
Neutral

Moving Averages

Name

Value

Action

SMA (20)
540.84
Bullish
EMA (20)
541.22
Bullish
VWMA (20)
540.91
Bullish
SMA (50)
541.89
Bullish
EMA (50)
541.52
Bullish
SMA (200)
541.09
Bullish
EMA (200)
542.16
Bullish
KAMA (200)
541.4
Bullish
DEMA (200)
540.14
Bullish

Thyrocare Technologies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Thyrocare Technologies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY8,665.765.62%0.55162829
BUY14,869.7824.83%0.66172814
BUY11,876.73-5.68%0.581911,645
BUY31,998.70-1.37%0.545092,762
HOLD1,04,112.7639.31%0.698896,812

Market expectation of Thyrocare Technologies Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Thyrocare Technologies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
148
134.74
154.25
156.91
177.36
165.92
187.16
193.03
216.53
195.53
223.95
240.02
Other Income
2.53
2.86
3.49
3.61
2.61
4.01
4.59
4.9
3.33
5.26
4.89
4.86
Total Income
150.53
137.6
157.74
160.52
179.97
169.93
191.75
197.93
219.86
200.79
228.84
244.88
Expenses
110.48
103.15
120.66
114.62
129.36
124.35
130.09
135.26
145.18
143.86
148.86
162.75
Operating Profit
37.52
31.59
33.59
42.29
48
41.57
57.07
57.77
71.35
51.67
75.09
77.27
Operating Profit Margin %
25.35%
23.45%
21.78%
26.95%
27.06%
25.05%
30.49%
29.93%
32.95%
26.43%
33.53%
32.19%
Profit Before Interest, Tax and Depreciation
40.05
34.45
37.08
45.9
50.61
45.58
61.66
62.67
74.68
56.93
79.98
82.13
Interest
1.13
1.07
1.12
0.99
0.76
0.6
0.7
0.78
0.59
-0.09
1.52
1.35
Depreciation
10.65
13.47
13.06
11.36
13.07
17.06
13.77
11.41
11.51
21.63
14.03
12.49
Profit Before Tax
28.27
19.91
22.9
33.55
36.78
27.92
47.19
50.48
62.58
35.39
64.43
68.29
Tax Paid
7.94
5.17
5.72
9.61
10.36
8.97
25.62
12.19
14.77
7.34
15.73
16.96
Profit After Tax
20.33
14.74
17.18
23.94
26.42
18.95
21.57
38.29
47.81
28.05
48.7
51.33
Total Net profit including share of profit / Loss from associate company
20.33
14.74
17.18
23.94
26.42
18.95
21.57
38.29
47.81
28.05
48.7
51.33
EPS
3.84
2.78
3.54
4.52
4.99
3.58
4.17
7.35
9.05
1.82
2.99
3.23
Actual EPS
3.84
2.78
3.54
4.52
4.99
3.58
4.17
7.35
9.05
1.82
2.99
3.23
Adjusted EPS
1.28
0.93
1.18
1.51
1.66
1.19
1.39
2.45
3.02
1.82
2.99
3.23
Diluted EPS
3.84
2.77
3.54
4.51
4.99
3.56
4.17
7.33
9.03
1.81
2.98
3.22

Thyrocare Technologies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
356.32
402.91
433.2
494.62
588.86
526.67
571.88
687.35
829.04
Other Income
23
10.61
8.24
12.43
29.25
9.6
9.76
14.83
18.38
Total Income
379.32
413.52
441.44
507.05
618.11
536.27
581.64
702.18
847.42
Expenses
213.79
248.68
267.26
323.45
354.15
406.62
434.45
498.43
573.16
Operating Profit
142.53
154.23
165.94
171.17
234.71
120.05
137.43
188.92
255.88
Operating Profit Margin %
40%
38.28%
38.31%
34.61%
39.86%
22.79%
24.03%
27.49%
30.86%
Profit Before Interest, Tax and Depreciation
165.53
164.84
174.18
183.6
263.96
129.65
147.19
203.75
274.26
Interest
0.44
0.61
1.85
0.87
2.37
2.35
4.2
3.05
2.8
Depreciation
20.1
26.17
31.91
30.28
33.87
38.71
47.01
55.26
58.58
Profit Before Tax
144.99
138.06
140.42
152.45
227.72
88.59
95.98
145.44
212.88
Tax Paid
51.71
52.92
52.01
39.32
51.58
24.23
26.49
54.69
50.03
Profit After Tax
93.28
85.14
88.41
113.13
176.14
64.36
69.49
90.75
162.85
Total Net profit including share of profit / Loss from associate company
93.28
85.14
88.41
113.13
176.14
64.36
69.49
90.75
162.85
EPS
17.39
15.95
16.74
21.41
33.3
12.16
13.42
17.13
10.27
Actual EPS
17.39
15.95
16.74
21.41
33.3
12.16
13.42
17.13
10.27
Adjusted EPS
5.8
5.32
5.58
7.14
11.1
4.05
4.47
5.71
10.27
Diluted EPS
17.34
15.91
16.71
21.37
33.24
12.14
13.4
17.08
10.24

Thyrocare Technologies Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
67.8
89.57
107.03
100.31
167.88
114.73
113.41
129.31
167.63
191.32
213.23
Cash Flow from Investing Activities
-17.68
-41.53
-43.22
-11.59
0.95
-48.66
-23.57
-38.99
-91.29
-52.52
-23
Cash Flow from Financing Activities
-44.96
-48.52
-63.87
-93.63
-164.78
-61.58
-89.41
-86.18
-84.81
-130.42
-169.59
Net Cash Flow
5.17
-0.46
-0.06
-4.91
4.05
4.49
0.43
4.14
-8.47
8.38
20.64

Thyrocare Technologies Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
71.11%
71.11%
71.11%
71.11%
71.06%
71.06%
71.06%
71.06%
60.93%
60.92%
60.92%
DII
13.55%
14.88%
14.9%
14.8%
14.67%
14.97%
14.54%
13.47%
20.51%
20.99%
20.92%
FII
0%
2.9%
2.49%
1.93%
2.77%
2.41%
3.23%
4.85%
4.95%
5.37%
5.44%
Public
11.65%
11.1%
11.5%
12.16%
11.49%
11.56%
11.17%
10.63%
13.61%
12.71%
12.72%
Total Outstanding Shares
5,29,52,676
5,29,52,676
5,29,52,676
5,29,52,676
5,29,91,800
5,29,93,451
5,29,94,447
5,29,94,447
15,91,61,691
15,91,65,315
15,91,65,315
Total Shareholders
68,844
64,823
61,636
59,377
56,666
57,403
54,566
54,142
77,619
73,377
73,064

Mutual Funds Buying / Exiting Thyrocare Technologies

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Thyrocare Technologies

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

HSBC Midcap Fund Direct Plan Growth

HSBC Midcap Fund Direct Plan Growth

₹304.89 Cr

₹74.62 Cr (+32.41%)

1.99%

Aditya Birla Sun Life ELSS Tax Saver Direct Plan Growth

Aditya Birla Sun Life ELSS Tax Saver Direct Plan Growth

₹215.32 Cr

₹37.64 Cr (+21.18%)

1.66%

Mutual Funds Exiting Thyrocare Technologies

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Nippon India Pharma Fund - Direct Plan - Growth Plan

Nippon India Pharma Fund - Direct Plan - Growth Plan

₹206.67 Cr

₹10.34 Cr (-4.77%)

2.45%

ICICI Prudential Dividend Yield Fund Direct Growth

ICICI Prudential Dividend Yield Fund Direct Growth

₹114.13 Cr

₹1.29 Cr (-1.12%)

1.91%

Thyrocare Technologies Corporate Actions

View detailed summary of the earnings and dividend history of Thyrocare Technologies.

  • Thyrocare Technologies Ltd Earnings Results

    Thyrocare Technologies Ltd’s net profit jumped 34.06% since last year same period to ₹52.19Cr in the Q1 2026-2027. On a quarterly growth basis, Thyrocare Technologies Ltd has generated 10.76% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Thyrocare Technologies Ltd Dividends May,2026

    In the quarter ending March 2026, Thyrocare Technologies Ltd has declared dividend of ₹7.00 per share on 07 May 2026 - translating a dividend yield of 2.55%.

    Read More about Dividends

Indices Featuring Thyrocare Technologies Stock

Check stock indices that include Thyrocare Technologies.

BSE Healthcare

₹50,207.25

-271.56 (0.54%)

Insights on Thyrocare Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 29.01 Cr → 52.19 Cr (in ₹), with an average increase of 24.1% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.37% to 5.44% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, THYROCARE has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 12.71% to 12.72% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 19.45% to 19.86% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 200.79 Cr → 244.88 Cr (in ₹), with an average increase of 9.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, THYROCARE has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 60.92% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, THYROCARE stock has moved down by -12.0%

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in 2000 and is one of the leading pan-India diagnostic chains, offering 636 distinct tests and 90 profiles of tests for early detection and management of various disorders and diseases. Additionally, they have set up Regional Processing Laboratories (RPLs) in 25 cities and Thryrocare International Holding Company (TIHC) in Mauritius has established a centre in Bahrain. In 2016, Thyrocare Technologies had a public offering that closed with an oversubscription of 75 times, and in 2018 acquired an Associate Company, Equinox Labs Private Limited, as well as bought back 958900 equity shares. In 2020, their services were negatively affected due to the Coronavirus, however, in 2021 they had a new promoter, Docon Technologies Private Limited, acquire 37656092 equity shares of the Company.As of March 31 2022, Thyrocare Technologies had a network of 1500 active channel partners and more than 9000 collection points spread across 500 districts in India and provided an extensive menu of over 700 tests, with more than 300 added within the year. Additionally, they installed automation for urine testing in 12 lab locations and Beckman Analysers in Zonal Processing Laboratories.

Revenue: ₹240.02Cr as on June 2026 (Q1 FY27)
Net Profit: ₹51.33Cr as on June 2026 (Q1 FY27)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
OrganisationThyrocare Technologies Ltd
HeadquartersNavi Mumbai
IndustryHealthcare
CEORahul Guha
E-voting on sharesClick here to vote

FAQs

What is Thyrocare Technologies share price today?

Thyrocare Technologies share price today stands at ₹538.5 as on . Thyrocare Technologies share today touched a day high of ₹549.45 and a low of ₹532.75.

What is the 52 week high and 52 week low range for Thyrocare Technologies share?

Thyrocare Technologies touched a 52 week high of ₹662 and a 52 week low of ₹342.55. Thyrocare Technologies share price today i.e. is trending at ₹538.5, which is -18.66% down from its 52 week high and 57.20% up from its 52 week low.

What is Thyrocare Technologies's market capitalisation today?

Thyrocare Technologies market capitalisation is ₹8,665.76 Cr as on .

How to buy Thyrocare Technologies shares?

To buy Thyrocare Technologies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for THYROCARE or Thyrocare Technologies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Thyrocare Technologies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Thyrocare Technologies trading volume today?

Thyrocare Technologies trading volume is 1.30L as on . This means that 1.30L shares of Thyrocare Technologies were bought and sold on the stock market during today's trading session.